The new guidelines for managing thyroid disease in pregnancy, set to be published in 2025, emphasize personalized treatment and shared decision-making. Key changes include not routine treatment with levothyroxine for patients with euthyroid TPO antibodies but monitoring their thyroid levels, as well as recommending treatment for subclinical hypothyroidism diagnosed in the first trimester but not in the second or third trimester. The guidelines also focus on spontaneous normalization of thyroid function during pregnancy, shared decision-making for overt hyperthyroidism, and managing thyroid nodules and cancer in pregnancy like outside of pregnancy. The updates aim to reflect recent evidence-based developments and improve readability and user-friendliness.
Source link
Update Coming for Thyroid Disease in Pregnancy Guidelines
